Pulmonary hypertension (PH) is a complex and progressive disease characterized by elevated pulmonary arterial pressure and pulmonary vascular resistance. This article aims to provide a comprehensive understanding of PH, its pathophysiology, clinical presentation, diagnosis, and management strategies.
PH is primarily a disease of the small pulmonary arteries, which undergo vasoconstriction, vascular remodeling, and thrombosis in situ. These changes lead to increased pulmonary vascular resistance, right ventricular overload, and eventually right heart failure if left untreated.
Patients with PH often present with dyspnea, fatigue, chest pain, syncope, and signs of right heart failure. The diagnosis of PH is made based on a mean pulmonary artery pressure ≥25 mmHg at rest, as measured by right heart catheterization. Additional diagnostic tools include echocardiography, pulmonary function tests, and computed tomography of the chest.
The management of PH is multidimensional and includes general measures, targeted drug therapy, and in severe cases, lung transplantation. General measures include supportive care, physical activity, and supplemental oxygen. Targeted drug therapies aim to reverse the pathophysiological changes in the pulmonary arteries. These include endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs. Lung transplantation is reserved for patients with advanced disease who fail to respond to medical therapy.
Understanding the fundamentals of PH is crucial for prompt diagnosis and effective management. The complexity of the disease necessitates a multidisciplinary approach and a thorough understanding of its pathophysiology, clinical presentation, and management strategies. By staying abreast of the latest research and treatment modalities, healthcare professionals can provide optimal care for patients with this challenging condition.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation